Rangers Bullpen Chaos: Martin's Return Masks a Deepening Relief Crisis

The Texas Rangers made a surface-level swap on Saturday, activating 40-year-old Chris Martin from the injured list while placing Jakob Junis on the 15-day IL with a right hip impingement. The transaction reads routine—one reliever in, one out—but the underlying bullpen math is grim. Jalen Beeks, who was closing in on activation after missing 24 days with lower back spasms, suffered a flexor tendon strain during his rehab and will require season-ending surgery. That's three high-leverage arms in flux across a compressed window, and Martin's return does not offset the loss.

Junis has been the Rangers' workhorse in relief, posting a 2.80 ERA over 31 appearances (35 1/3 innings) with five saves. He was available most days and threw strikes; his absence is immediate and material. Martin, by contrast, carries injury red flags that complicate the relief calculus. He's missed 61 games across two separate right shoulder impingement stints—31 games from mid-April through mid-May, then another 30-game absence covering all of June. His 7.84 ERA in 12 games this season (1-1 record) is not a sign of sharpness; it's evidence of a pitcher still finding his way back from structural issues. At 40, Martin's durability is not a given either, even if his mechanics are intact.

Jack Leiter's timeline compounds the relief pressure. The 26-year-old starter underwent arthroscopic surgery on June 23 to remove an os trigonum bone from behind his right ankle—a procedure that didn't require repair, only removal. Leiter was already struggling (9.88 ERA in three June starts, all losses) before the surgery, and he's now in a fog on his return timeline. He's optimistic about pitching again this season, but acknowledged the blueprint is unclear. Even if Leiter returns in August or September, the Rangers are operating without a healthy, reliable fourth or fifth starter into the All-Star break and beyond.

For wagering purposes, this cascades into two distinct angles. First, Texas's bullpen ERA and blown-save rate are now live concerns. Junis's removal strips out a 2.80-ERA arm that was eating high-leverage innings; Martin's track record and age suggest he'll chew up leverage but not consistently deliver dominance. Second, the Rangers' team total moves into fade territory for July games, particularly those without a clear starter advantage. Without Leiter in the mix and with Junis sidelined, Texas lacks the relief depth to pitch multiple close games on back-to-back nights. Overs on Rangers team totals in the next 7-10 days should be attractive, especially against teams with functional bullpens that can manufacture runs in the 6th and 7th innings when Texas is forced to lean on untested or recovering relievers.

The Rangers remain in the AL West race, but this injury cluster is not a minor inconvenience. It's a structural problem that will punish them in tight games through the end of July.